- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05730335
A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device in Adult Participants for the Appearance of Cellulite
A Multi-Center, Prospective Study to Evaluate the Safety and Effectiveness of Multi-Treatment Regimen With Zeltiq Aesthetics, Inc. Rapid Acoustic Pulse (RAP)™ Device for the Improvement in the Appearance of Cellulite
Cellulite is the rippling or dimpling of the skin most commonly located on the thighs and buttocks of women. Its appearance and texture are often likened to that of "cottage cheese" or an orange peel. Rapid Acoustic Pulse (RAP) is an electrohydraulic (EH) device developed to improve the appearance of cellulite through microscopic disruption of the connection between the skin and underlying tissue leading to a reduction in the severity of dimples and ridges. The purpose of this study is to assess adverse events and effectiveness of RAP in adults seeking treatment of cellulite.
RAP is an FDA approved device for the long-term improvement in the appearance of cellulite in the buttocks and thighs. Participants 18-50 years of age seeking treatment of cellulite will be enrolled. Up to 60 participants will be enrolled in the study at 4 sites in the United States.
Participants will receive 2 separate cellulite treatment sessions. Each treatment session will consist of RAP treatment delivered to bilateral thigh and/or buttock areas using the same treatment settings for both sides. The study duration is up to 60 weeks.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a clinic. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60654
- Chicago Cosmetic Surgery and Dermatology
-
-
New Hampshire
-
Nashua, New Hampshire, United States, 03060
- Skin and Laser Surgery Center of New England
-
-
New York
-
New York, New York, United States, 10003
- Union Derm
-
-
Texas
-
Bellaire, Texas, United States, 77401
- Bellaire Dermatology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants seeking treatment of cellulite in the thigh and/or buttock areas.
- Areas of moderate to severe cellulite on bilateral thigh and/or buttock using the Cellulite Dimple - At Rest Scale at Baseline with grades of 2 or 3 based on review of photos taken under the same lightening conditions planned for the trial.
- Participant will not have had invasive or energy-based cellulite (liposuction, subcision, RF, laser, ESWT, cryo-lipolysis, muscle stimulation, etc.) treatments in the treatment areas in the prior 12 months.
- Participant will not have used topical based cellulite treatments for prior 3 months and will not use during the trial
- Participant will not have used spray-on tanning treatments for 3 months prior to or during the term of the trial.
Exclusion Criteria:
- Metal or plastic implants (vascular stent, or implants in the hips, knees, etc.) in the treatment areas.
- Active electronic implants such as pacemakers, defibrillators
- History of coagulopathy and/or on anticoagulant medication
- Skin disorders (skin infections or rashes, psoriasis, etc.) in the treatment areas.
- Medical disorder that would hinder wound healing or immune response.
- Any surgical procedure in the treatment areas in the prior 3 months or planned during the duration of the study.
- Any other condition/disease/situation which, as deemed by the PI, would preclude participant from safely participating in or completing the study visits or that may confound study results.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rapid Acoustic Pulse (RAP)
Participants will receive 2 separate RAP cellulite treatments sessions.
|
Transdermal Rapid Acoustic Pulse Treatments
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Participants with Improvement in the Appearance of Cellulite as Determined by Blinded Independent Physician Reviewers (IPR)
Time Frame: Week 16
|
The number of before and after side-by-side photographs correctly identified by at least 2 of 3 blinded reviewers from the IPR panel.
|
Week 16
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Participants with "Agree" or "Strongly Agree" Responses to the Participant Satisfaction Survey in the Improvement in Appearance of Cellulite
Time Frame: Week 16
|
The study participant demonstrates improvement by selecting ''Agree" or "Strongly Agree" as answers to the Participant Satisfaction Survey statement - 'In comparison to the pre-treatment photo, the 12 week photograph of the treatment area appears improved.'
|
Week 16
|
Number of Participants with Adverse Events
Time Frame: 60 Weeks
|
An adverse event (AE) is defined as any untoward medical occurrence in a participant or clinical investigation participant administered by a medical device which does not necessarily have a causal relationship with the treatment.
|
60 Weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Zeltiq Aesthetics, Zeltiq Aesthetics
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M24-262
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cellulite
-
Endo PharmaceuticalsCompletedEdematous Fibrosclerotic Panniculopathy (Cellulite)United States
-
Galderma R&DCompletedCellulite of the ButtocksBrazil
-
DSM Nutritional Products, Inc.TerminatedCellulite (Orange Peel Skin)Brazil
-
Nutrasource Pharmaceutical and Nutraceutical Services...Completed
-
InMode MD Ltd.Completed
-
Syneron MedicalTerminatedCircumference Reduction | Cellulite ReductionUnited States
-
Cairo UniversityNot yet recruitingEfficacy of Treatment of Cellulite Using Carboxy Therapy
-
Cutera Inc.CompletedTreatment for Cellulite on the Stomach and FlanksUnited States
-
Endo PharmaceuticalsCompletedEdematous Fibrosclerotic Panniculopathy (Cellulite)United States
-
Caliway Biopharmaceuticals Co., Ltd.Active, not recruiting
Clinical Trials on Rapid Acoustic Pulse
-
Zeltiq AestheticsRecruiting
-
SolitonCompletedCelluliteUnited States
-
SolitonCompletedCelluliteUnited States
-
SolitonUnited States Naval Medical Center, San DiegoNot yet recruitingScars, Hypertrophic
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of CambridgeCompletedDysphagia, OropharyngealUnited Kingdom
-
Michael Kyle RitchieWest Virginia Clinical and Translational Science InstituteCompletedCardiac Arrest | Circulatory FailureUnited States
-
Caroline LustenbergerActive, not recruiting
-
Boston Scientific CorporationBTG International Inc.CompletedPulmonary Embolism and ThrombosisUnited States, United Kingdom, Switzerland, Austria, France, Germany, Netherlands, Turkey
-
ANM Adaptive Neuromodulation GmbHCompletedChronic Tonal TinnitusGermany
-
University of BernCompletedHealthy | Alzheimer Disease | Mild Cognitive ImpairmentSwitzerland